Drug Search Results
Using advanced filters...
Advanced Search [+]

MF-4181

Alternative Names: mf-4181, mf4181, mf 4181
Clinical Status: Inactive
Latest Update: 2013-03-29
Latest Update Note: Clinical Trial Update

Product Description

a hydrogel scaffold

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Halscion
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Recent & Upcoming Milestones

Highest Development Phases

Phase 2: Keloid|Other

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

HAL-0127

P2

Completed

Keloid

2011-12-01

2019-03-19

Treatments

HAL-0082

P2

Completed

Other

2011-05-01

2019-03-19

Recent News Events

Date

Type

Title